揭示硫化:神经保护和神经调节的新前沿
Ghizal Fatima1, Abbas Ali Mahdi2, Hekmat B Alhmadi3
1Department of Biotechnology, Era University, Lucknow, India.
Indian journal of clinical biochemistry : IJCB
|September 12, 2025
概括
硫化 (H2S) 是神经保护和神经调节的关键分子,具有抗氧化和抗炎功效. 虽然对阿尔茨海默氏症和帕金森症等神经退行性疾病有希望,但临床应用仍然存在挑战.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 硫化 (H2S) 从有毒气体转变为一种重要的内源性神经调节剂.
- 由CBS,CSE和3-MST酶产生,H2S具有抗炎,抗氧化和抗丧的特性.
- H2S影响谷氨酸,多巴胺和GABA系统,影响突触传输和可塑性.
研究的目的:
- 审查H2S的神经保护和神经调节作用.
- 探索H2S在神经退行性疾病和中风中的治疗潜力.
- 总结目前的研究和基于H2S的治疗方法的未来方向.
主要方法:
- 在神经保护和神经调节中对H2S进行临床前研究的文献综述.
- 对H2S对细胞机制,神经递质系统和疾病模型的影响的分析.
- 检查阿尔茨海默病,帕金森病和中风模型中的治疗应用.
主要成果:
- H2S可以减少氧化应激,线粒体破坏和神经元损伤.
- 它调节突触传输,可塑性和神经递质系统.
- 临床前数据显示,H2S可以防止粉样β毒性,多巴胺能神经元损失和缺血性中风损伤.
结论:
- H2S显示出显著的神经保护和神经调节的潜力.
- 在阿尔茨海默病,帕金森病和中风的治疗应用是有希望的.
- 在临床转化中需要解决H2S稳定和输送系统的挑战.
相关概念视频
Preparation and Reactions of Sulfides
5.7K
Sulfides are the sulfur analog of ethers, just as thiols are the sulfur analog of alcohol. Like ethers, sulfides also consist of two hydrocarbon groups bonded to the central sulfur atom. Depending upon the type of groups present, sulfides can be symmetrical or asymmetrical. Symmetrical sulfides can be prepared via an SN2 reaction between 2 equivalents of an alkyl halide and one equivalent of sodium sulfide.
5.7K
The Blood-brain Barrier
52.4K
Overview
52.4K
Neurogenesis and Regeneration of Nervous Tissue
1.6K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
1.6K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
834
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
834


